Patients failing to tell GPs about 'serious' hypoglycaemia
Over a third of type 2 diabetes patients are unaware of the side effects of the medication they are ...
Night-time hypoglycaemia risk cut by new insulin
Patients' risk of night-time hypoglycaemia is lower when treated with a new, as-yet-unlicensed insul...
Diabetes treatment response determined by genetic variation
Genetic variation plays a large part in explaining why metformin is much better at lowering blood gl...
Intensive diabetes control below QOF targets 'is not evidence-based'
Aiming for glycaemic control below QOF targets in type-2 diabetes will not reduce patient mortality ...
Route from high-fat diet to type-2 diabetes uncovered
Molecular pathways by which high-fat diets contribute to type-2 diabetes have been uncovered by a US...
Enzyme boost for diabetics
Administering the enzyme hyaluronidase with meal-time insulin injections could help improve blood su...
Diabetes drug can cut hypo rate and boost weight loss
A new class of oral anti-diabetic drug may cut hypoglycaemic events and lead to weight loss compared...
Avandia should be suspended, says European regulator
The diabetes drug Avandia (rosiglitazone) should be suspended from use in Europe, according to the E...
Fear of hypoglycaemia blocks HbA1c control, study says
Patient fear of hypoglycaemia remains an important barrier to optimal glucose control, research sugg...
DPP-4 therapy cuts weight gain and hypoglycaemia
Treating type-2 diabetes with dipeptidyl peptidase-4 (DPP-4) inhibitors reduces patients' risk of we...
